Trial Information
Inclusion Criteria:
- Irregular menses or anovulaty cycles
- High free testosterone > 0.035 nmol/l or hirsutism
- PCO in vaginal US Criteria 1 and 2 OR 2 and 3
Exclusion Criteria:
- Age > 18 years
- Postmenopausal
- Diagnosis diabetes mellitus
- Use of medicine known to affect hormones measured in the project
- Pregnancy or planned pregnancy during study period
- Non-Caucasian
- Previous tromboembolic disease
- Heavy smoker > 35 years and BMI > 35 kg/m2
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Changes in fasting insulin and area under the curve for insulin (2 hours)
Principal Investigator
Marianne Andersen, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Odense University Hospital
Authority:
Denmark: National Board of Health
Study ID:
027
NCT ID:
NCT00451568
Start Date:
March 2007
Completion Date:
April 2010
Related Keywords:
- Polycystic Ovary Syndrome
- Polycystic ovary syndrome
- Polycystic Ovary Syndrome